Topics

FDA Allows Patients to use VERO’s Nitric Oxide at Home

04:42 EDT 26 Mar 2020 | Contract Pharma

Genosyl DS system facilitates outpatient use of inhaled nitric oxide in the treatment of cardiopulmonary symptoms associated with COVID-19

Original Article: FDA Allows Patients to use VERO’s Nitric Oxide at Home

NEXT ARTICLE

More From BioPortfolio on "FDA Allows Patients to use VERO’s Nitric Oxide at Home"

Quick Search